ADC Therapeutics SA (NYSE:ADCT)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ADCT

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ADCT

  • Market Cap$1.938bn
  • SymbolNYSE:ADCT
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINCH0499880968

Company Profile

ADC Therapeutics SA is a United States-based clinical-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ADCT-402, ADCT-301, ADCT-602, and ADCT-601.

Latest ADCT news

Currently there for this company. Visit our news hub for other news .